X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ADCOCK INGRAM
Jun-14
ALKEM LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,589373-   
Low Rs1,232269-   
Sales per share (Unadj.) Rs417.5111.1-  
Earnings per share (Unadj.) Rs56.3-28.0-  
Cash flow per share (Unadj.) Rs64.7-23.2-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.987.2-  
Shares outstanding (eoy) m119.57168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.9 116.8%   
Avg P/E ratio x25.1-11.5 -218.2%  
P/CF ratio (eoy) x21.8-13.9 -157.3%  
Price / Book Value ratio x4.83.7 130.6%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,65354,239 310.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m9,1713,404 269.4%   
Avg. sales/employee Rs ThNM4,366.6-  
Avg. wages/employee Rs ThNM793.0-  
Avg. net profit/employee Rs ThNM-1,100.3-  
INCOME DATA
Net Sales Rs m49,91518,746 266.3%  
Other income Rs m1,645131 1,253.2%   
Total revenues Rs m51,56118,877 273.1%   
Gross profit Rs m8,482-3,249 -261.1%  
Depreciation Rs m1,006809 124.3%   
Interest Rs m671508 132.1%   
Profit before tax Rs m8,451-4,434 -190.6%   
Minority Interest Rs m-114-12 920.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606277 579.6%   
Profit after tax Rs m6,731-4,724 -142.5%  
Gross profit margin %17.0-17.3 -98.1%  
Effective tax rate %19.0-6.2 -304.1%   
Net profit margin %13.5-25.2 -53.5%  
BALANCE SHEET DATA
Current assets Rs m27,06213,730 197.1%   
Current liabilities Rs m15,3247,725 198.4%   
Net working cap to sales %23.532.0 73.4%  
Current ratio x1.81.8 99.4%  
Inventory Days Days67111 60.0%  
Debtors Days Days41124 33.3%  
Net fixed assets Rs m12,6108,003 157.6%   
Share capital Rs m23987 274.7%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,02714,714 238.1%   
Long term debt Rs m1,2125,171 23.4%   
Total assets Rs m54,38727,795 195.7%  
Interest coverage x13.6-7.7 -175.9%   
Debt to equity ratio x00.4 9.8%  
Sales to assets ratio x0.90.7 136.1%   
Return on assets %13.6-15.2 -89.7%  
Return on equity %19.2-32.1 -59.9%  
Return on capital %24.9-19.8 -125.5%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,2591,600 453.6%  
From Investments Rs m1,864-491 -379.4%  
From Financial Activity Rs m-9,2734,693 -197.6%  
Net Cashflow Rs m-1505,801 -2.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.15 Rs / ZAR

Compare ALKEM LABORATORIES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: TORRENT PHARMA  PFIZER  JUBILANT LIFE SCIENCES  SHASUN PHARMA  WYETH LTD  



Today's Market

Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)

Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jul 18, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS